The Global Basal Insulin Market Growth Accelerated By Increasing Prevalence Of Diabetes
The basal insulin market comprises medicines that help in maintaining consistent levels of insulin in the body for people with type 1 and type 2 diabetes. These drugs control blood glucose levels by slowly releasing insulin at a constant rate throughout the day. With the growing burden of diabetes worldwide due to rapid urbanization and lifestyle changes, the need for effective management of the disease has increased significantly.
The global Basal Insulin Market is estimated to be valued at US$
18.78 Mn in 2024 and is expected to
exhibit a CAGR of 5.3% over the forecast period 2024 to 2031, as highlighted
in a new report published by Coherent Market Insights.
Market key trends:
One of the key trends driving the basal insulin market is the increasing
prevalence of diabetes. As per latest statistics by the International Diabetes
Federation, approximately 537 million adults were living with diabetes in 2021
globally which is projected to reach 643 million by 2030 and 783 million by
2045. Moreover, diabetes resulted in 6.7 million deaths globally in 2021. Basal
insulin plays a crucial role in managing diabetes by maintaining a constant
supply of insulin in the body throughout the day and preventing hyperglycemia.
Thus, rising cases of diabetes has augmented the demand for basal insulin
worldwide. Furthermore, growing awareness about diabetes self-management and
improved reimbursement policies have also propelled the market growth.
Segment Analysis
The global basal insulin market is segmented on the basis of product type into
long-acting insulin and intermediate-acting insulin. The long-acting insulin segment
dominates the market and accounts for around 70% market share in 2024. This is
because long-acting insulin provides steady basal level of insulin throughout
the day with just one injection compared to multiple injections required by
intermediate-acting insulin.
Key Takeaways
The global Basal
Insulin Market Size is expected to witness high growth over the
forecast period of 2024-2031. The global basal insulin market is estimated to
be valued at US$ 18.78 Mn in 2024 and is expected to exhibit a CAGR of 5.3% over the forecast period 2024 to 2031.
North America dominates the
basal insulin market in 2024 with a share of around 40% due to high prevalence
of diabetes in the region. However, Asia Pacific region is expected to grow at
the fastest pace during the forecast period of 2024-2031 for the basal insulin
market. Factors such as rapidly growing geriatric population, increasing
healthcare expenditure, rising prevalence of diabetes due to changing lifestyle
and rapid urbanization are driving the growth of basal insulin market in Asia
Pacific region. Moreover, growing awareness about diabetes treatment and
management in emerging countries of Asia Pacific is further fueling the market
growth.
Key players operating in the basal insulin market are 3M Company, Turtle Wax,
Inc., Meguiar's, Inc., Simoniz USA, Inc., WD-40 Company, Quixx GmbH, Langka
Corporation, Scholl Concepts GmbH, WÃ1⁄4rth Group, BARDAHL Manufacturing
Corporation, Gtechniq Ltd., Mothers Polishes, Waxes and Cleaners, SONAX GmbH,
Chemical Guys, Surf City Garage.
Explore more
related article on this topic: https://www.pressreleasebulletin.com/basal-insulin-market-is-driven-by-increasing-prevalence-of-diabetes/
https://whotimes.com/stock-music-market-an-ever-evolving-industry/

Comments
Post a Comment